Pharmafile Logo
Pharmafocus logo
Advanced Search

irritable bowel syndrome

Showing 4 posts of 4 posts found.

EnteroBiotix begins phase 2 trial of IBS treatment

April 3, 2024
Research and Development EnteroBiotix, Gastrointestinal tract, IBS, irritable bowel syndrome

EnteroBiotix has announced that it has dosed the first patient in its multi-centre, randomised, double-blind, placebo controlled clinical trial, which …

News

Immune system exhaustion associated with irritable bowel syndrome

June 21, 2017
Research and Development IBS, irritable bowel syndrome, t cells

Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …

News
allergan

IBS-D treatment Truberzi receives positive opinion from CHMP

July 26, 2016
Manufacturing and Production, Sales and Marketing Allergan, EU, Truberzi, diarrhoea. CHMP, irritable bowel syndrome

Global pharmaceutical company Allergan has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of …

News
Enterome logo

Takeda and Enterome collaborate on new therapeutics for stomach disorders

January 6, 2016
Research and Development Enterome, Takeda, gastrointestinal, inflammatory bowel syndrome, irritable bowel syndrome

Takeda and Enterome Bioscience have entered a drug discovery collaboration to research and develop potential new therapeutics for disorders including …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026